Vanillic acid attenuates Aβ1-42-induced oxidative stress and cognitive impairment in mice

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Ul Amin, Faiz ^a   Shah, Shahid Ali ^a   Kim, Myeong Ok ^a  

^a Gyeongsang National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ASPARTIC PROTEINASE; BACE1 PROTEIN, MOUSE; GLYCOGEN SYNTHASE KINASE 3BETA; NEUROPROTECTIVE AGENT; NFE2L2 PROTEIN, MOUSE; PROTEIN AGGREGATE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SECRETASE; TRANSCRIPTION FACTOR NRF2; VANILLIC ACID;

ALZHEIMER DISEASE; ANIMAL; APOPTOSIS; ASTROCYTE; CELL LINE; COGNITIVE DEFECT; DRUG EFFECT; GENETICS; MEMORY DISORDER; METABOLISM; MICROGLIA; MOUSE; NERVE CELL; OXIDATIVE STRESS; PATHOLOGY; PROTEIN DEGRADATION; PROTEINOSIS; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; APOPTOSIS; ASPARTIC ACID ENDOPEPTIDASES; ASTROCYTES; CELL LINE; COGNITIVE DYSFUNCTION; GLYCOGEN SYNTHASE KINASE 3 BETA; MEMORY DISORDERS; MICE; MICROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PROTEIN AGGREGATES; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; VANILLIC ACID;

EID: 85009799669     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep40753     Document Type: Article

References (79)

1. Lambracht-Washington, D. & Rosenberg, R. N. Advances in the development of vaccines for Alzheimer's disease. Discov Med. 15, 319-326 (2013).
2. Coomaraswamy, J. et al. Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease. Proc Natl Acad Sci USA 107, 7969-7974 (2010).
3. Chan, K. H. et al. Adiponectin is protective against Oxidative stress induced cytotoxicity in Amyloid-beta neurotoxicity. PLoS ONE 7, 52354 (2012).
4. Lamert, M. P. et al. Diffusable, nonfibrillar ligands derived from Ab1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95, 6448-6453 (1998).
5. Jhoo, J. H. et al. Beta-Amyloid (1-42)-induced learning and memory deficits in mice: Involvement of oxidative burdens in the hippocampus and cerebral cortex. Behav Brain Res 155, 185-196 (2004).
6. Texel, S. J. & Mattson, M. P. Impaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer's disease. Antioxid Redox Signal 14, 1519-1534 (2011).
7. López, N., Tormo, C., De, B. I., Llinares, I. & Alom, J. Oxidative stress in Alzheimer's disease and mild cognitive impairment with high sensitivity and specificity. J Alzheimers Dis. 33, 823-829 (2013).
8. Hamilton, A. & Holscher, C. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease. Brain Res 1449, 83-93 (2012).
9. Butterfield, D. A. beta-Amyloid-Associated free radical oxidative stress and neurotoxicity: Implications for Alzheimer's disease. Chem Res Toxicol 10, 495-506 (1997).
10. Sultana, R. & Butterfield, D. A. Oxidative modification of brain proteins in Alzheimer's disease: Perspective on future studies based on results of redox proteomics studies. J Alzheimers Dis. 1, 243-251 (2013).
11. Sies, H. Oxidative stress: A concept in redox biology and medicine. Redox Biol. 4, 180-183 (2015).
12. Lushchak, V. I. Free radicals, reactive oxygen species, oxidative stress and its classification. Chem Biol Interact. 224, 164-175 (2014).
13. Coyle, J. T. & Puttfarcken, P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-95 (1993).
14. Chauhan, V. & Chauhan, A. Oxidative stress in Alzheimer's Disease. Pathophysiology 13, 195-208 (2006).
15. Di, C. M., Giacomazza, D., Picone, P., Nuzzo, D. & San, B. P. L. Are oxidative stress and mitochondrial dysfunction the key players in the neurodegerative diseases Free Radic. Res. 46, 1327-1338 (2012).
16. Gupta, V. K. & Sharma, S. K. Plants as natural antioxidants. Nat. Prod. Radiance 5, 326-334 (2005).
17. Rathore, G. S., Suthar, M., Pareek, A. & Gupta, R. N. Nutritional antioxidants: A battle for better health. J. Nat. Pharm 2, 2-14 (2011).
18. Breinholt, V. In Natural Antioxidants and Anticarcinogens in Nutrition, Health and Disease; Kumpulainen, J., Salonen, J. Eds. The Royal Society of Chemistry: Cambridge, UK, (1999).
19. Chou, T. H., Ding, H. Y., Hung, W. J. & Liang, C. H. Antioxidative characteristics and inhibition of alpha-melanocyte-stimulating hormone-stimulated melanogenesis of vanillin and vanillic acid from Origanum vulgare. Exp. Dermatol. 19, 742-750 (2010).
20. Singh, J. C. et al. Cognitive effects of vanillic acid against streptozotocin-induced neurodegeneration in mice. Pharm Biol. 53, 630-6 (2015).
21. Mattila, P. & Kumpulainen, J. Determination of free and total phenolic acids in plant-derived foods by HPLC with diode-Array detection. J Agric Food Chem 50, 3660-7 (2002).
22. Dhananjaya, B. L., Nataraju, A., Raghavendra Gowda, C. D. Sharath, B. K. & D'Souza, C. J. Vanillic acid as anovel specific inhibitor of snake venom 5' -nucleotidase: A pharmacological tool in evaluating the role of the enzyme in snake envenomation. Biochemistry 74, 1315-1319 (2009).
23. Varma, R. S., Shukla, A. & Chatterjee, R. K. Evaluation of vanillic acid analogues as a new class of antifilarial agents. Indian J. Exp. Biol. 331, 819-821 (1993).
24. Delaquis, P., Stanich, K. & Toivonen, P. Effect of pH on the inhibition of Listeria spp.by vanillin and vanillic acid. J. Food Prot. 68, 1472-1476 (2005).
25. Kim, M. C. et al. Vanillic acid inhibits inflammatory mediators by suppressing NF- B in lipopolysaccharide-stimulated mouse peritoneal macrophages. Immunophar-macol. Immunotoxicol 33, 525-532 (2011).
26. Tai, A., Sawano, T. & Ito, H. Antioxidant properties of vanillicacid esters in multiple antioxidant assays. Biosci. Biotechnol. Biochem. 76, 314-318 (2012).
27. Avramovich-Tirosh, Y. et al. Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron-chelating-Antioxidants, M-30 and green tea polyphenol, EGCG. Curr Alzheimer Res 4, 403-411 (2007).
28. Olanow, C. W. A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's disease. Mov Disord 8, 1-7 (1993).
29. Egea, J., Rosa, A. O., Cuadrado, A., García, A. G. & López, M. G. Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress. J Neurochem. 102, 1842-1852 (2007).
30. Li, L., Li, W., Jung, S. W., Lee, Y. W. & Kim, Y. H. Protective effects of decursin and decursinol angelate against amyloid β -proteininduced oxidative stress in the PC12 cell line: The role of Nrf2 and antioxidant enzymes. Biosci Biotechnol Biochem 75, 434-442 (2011).
31. Rojo, A. et al. Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death. Mol Cell Neurosci 39, 125-132 (2008a).
32. Rojo, A., Sagarra, M. R. & Cuadrado, A. GSK-3beta downregulates the transcription factor Nrf2 after oxidant damage: Relevance to exposure of neuronal cells to oxidative stress. J Neurochem 105, 192-202 (2008b).
33. Wu, D. C. et al. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1, 2, 3, 6-Tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22, 1763-1771 (2002).
34. Gao, H. M., Liu, B., Zhang & W. Hong J. S. Novel anti-inflammatory therapy for Parkinson's disease. Trends Pharmacol Sci 24, 395-401 (2003).
35. Calabrese, V. et al. Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity. Mol Aspects Med 32, 279-304 (2011).
36. Terai, K., Matsuo, A. & Mcgeer, P. L. Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease. Brain Res 735, 159-168 (1996).
37. Zhang, Z. H. et al. Hydroxy-safflor yellow A attenuates Aβ 1-42-induced inflammation by modulating the JAK2/STAT3/NF- B pathway. Brain Res 14, 72-80 (2014).
38. Chao, D. T. & Korsmeye, S. J. Bcl-2 family: Regulators of cell death. Annu. Rev. Immunol 16, 395-419 (1998).
39. Cancino, L. G. et al. STI571 prevents apoptosis, tau phosphorylation and behavioral impairments induced by Alzheimer's β -Amyloid deposits. Brain 131, 2425-2442 (2008).
40. Awasthi, A., Matsunaga, Y. & Yamada, T. Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides. Exp Neurol 196, 282-289 (2005).
41. Berger, N. A. Poly (ADP-ribose) in the cellular response to DNA damage. Radiat Res 101, 4-15 (1985).
42. Strosznajder, J. B., Jeceko, H. & Stroznnajder, R. P. Effect of amyloid beta peptide on poly (ADP-ribose) polymerase activity in adult and aged rat hippocampus. Acta Biochim. Pol. 47, 847-854 (2000).
43. Gallagher, J. J., Minogue, A. M. & Lynch, M. A. Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation. Neurodegener Dis. 11, 33-41 (2013).
44. Markesbery, W. R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134-147 (1997).
45. Pappolla, M. A. et al. Evidence of oxidative stress and in vivo neurotoxicity of β -Amyloid in a transgenic mouse model of Alzheimer's disease. A chronic oxidative paradigm for testing antioxidant therapies in vivo. Am. J. Pathol. 152, 871-877 (1998).
46. Goldsbury, C., Whiteman, I. T., Jeong, E. V. & Lim, Y. A. Oxidative stress increases levels of endogenous amyloid-β peptides secreted from primary chick brain neurons. Aging Cell 7, 771-775 (2008).
47. Kanski, J., Aksenova, M., Stoyanova, A. & Butterfield, D. A. Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: Structure-Activity studies. J. Nutr. Biochem. 13, 273-281 (2002).
48. Mancuso, C. et al. Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front Biosci. 12, 1107-1123 (2007).
49. Dumont, M. et al. Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J 23, 2459-2466 (2009).
50. Sang, S. et al. Antioxidative phenolic compounds isolated from almond skins (Prunus amygdalus Batsch). J Agric Food Chem. 50, 2459-63 (2002).
51. Shyamala, B. N., Naidu, M. M., Sulochanamma, G. & Srinivas, P. Studies on the antioxidant activities of natural vanilla extract and its constituent compounds through in vitro models. J Agric Food Chem. 55, 7738-43 (2007).
52. Woodruff-pak, D. S. Animal model of Alzheimer's disease: Therapeutic implications. J Alzheimer's Dis 15, 507-521 (2008).
53. Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid b-peptide. Nat Rev Mol Cell Biol 8, 101-112 (2007).
54. Liang, B., Duan, B. Y., Zhou, X. P., Gong, J. X. & Luo, Z. G. Calpain activation promotes BACE1 expression, amyloid precursor protein processing,and amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Biol Chem 285, 27737-27744 (2010).
55. Yang, L. B. et al. Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9, 3-4 (2003).
56. Wan, L. et al. β -Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease. Free Radic Biol Med 50, 122-129 (2011).
57. Abdul, H. M., Sultana, R., St, C. D. K., Markesbery, W. R. & Butterfield, D. A. Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age. Free Radic Biol Med 45, 1420-1425 (2008).
58. Stanely, M. Prince, P. Rajakumar, S. & Dhanasekar, K. Protective effects of vanillic acid on electrocardiogram, lipid peroxidation, antioxidants, proinflammatory markers and histopathology in isoproterenol induced cardiotoxic rats. European Journal of Pharmacology 668, 233-240 (2011b).
59. Khodagholi, F., Eftekharzadeh, B., Maghsoudi, N. & Rezaei, P. F. Chitosan prevents oxidative stress-induced amyloid beta formation and cytotoxicity in NT2 neurons: Involvement of transcription factors Nrf2 and NF-kappaB. Mol Cell Biochem 337, 39-51 (2010).
60. Kanninen, K. et al. Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 106, 16505-16510 (2009).
61. Choudhry, F., Howlett, D. R., Richardson, J. C., Francis, P. T. & Williams, R. J. Pro-oxidant diet enhances β/ secretase-mediated APP processing in APP/PS1 transgenic mice. Neurobiol Aging 33, 960-968 (2012).
62. Eftekharzadeh, B., Maghsoudi, N. & Khodagholi, F. Stabilization of transcription factor Nrf2 by tBHQ prevents oxidative stressinduced amyloid beta formation in NT2N neurons. Biochimie 92, 245-253 (2010).
63. Hui, Y. et al. Long-Term overexpression of hemeoxygenase 1 promotes tau aggregation in mouse brain by inducing tau phosphorylation. J Alzheimers Dis 26, 299-313 (2011).
64. Kamalvand, G., Pinard, G. & Ali, K. Z. Heme-oxygenase-1 response, a marker of oxidative stress, in a mouse model of AA amyloidosis. Amyloid 10, 151-159 (2003).
65. Rada, P. et al. Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β -TrCP axis. Mol Cell Biol 32, 3486-3499 (2012).
66. Maqbool, A., Lattke, M., Wirth, T. & Baumann, B. Sustained, neuronspecific IKK/NF-KB activation generates a selective neuroinflammatory response promoting local neurodegeneration with aging. Mol Neurodegener 8, 40, doi: 10.1186/1750-1326-8-40 (2013).
67. Fernandez, M. A., Saenz, M. T. & Garcia, M. D. Anti-inflammatory activity in rats and mice of phenolic acids isolated from Scrophularia frutescens. J. Pharm. Pharmacol 50, 1183-1186 (1998).
68. Lauren, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W. & Strittmatter, S. M. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-b oligomers. Nature 457, 1128-1132 (2009).
69. Sairanen, T. et al. Neuronal caspase-3 and PARP-1 correlate differentially with apoptosis and necrosis in ischemic human stroke. Acta Neuropatho 118, 541-552 (2009).
70. Love, S., Barber, R. & Wilcock, G. K. Increased poly (ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease. Brain 122, 247-256 (1999).
71. Tu, S., Okamoto, S., Lipton, S. A. & Xu, H. Oligomeric Aβ -induced synaptic dysfunction in Alzheimer's disease. Mol Neurodegener 9, 48 (2014).
72. Canas, P. M. et al. Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by b-Amyloid peptides via p38 mitogenactivated protein kinase pathway. J Neurosci 29, 14741-14751 (2009).
73. Ehrlich, I. & Malinow, R. Postsynaptic density 95 controls AMPA receptor incorporation during long-Term potentiation and experience-driven synaptic plasticity. J Neurosci 24, 916-927 (2004).
74. Broadbent, N. J., Squire, R. L. & Clark, R. E. Spatial memory, recognition memory, and the hippocampus. Proc Natl Acad Sci USA 101, 14515-14520 (2004).
75. Shah, S. A., Lee, H. Y., Bressan, R. A., Yun, D. J. & Kim, M. O. Novel osmotin attenuates glutamate-induced synaptic dysfunction and neurodegeneration via the JNK/PI3K/Akt pathway in postnatal rat brain. Cell Death Dis. 5, 1026 (2014).
76. Ali, T., Yoon, G. H., Shah, S. A., Lee, H. Y. & Kim, M. O. Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus. Sci. Rep. 5, 11708 (2015).
77. Amin, F. U., Shah, S. A. & Kim, M. O. Glycine inhibits ethanol-induced oxidative stress, neuroinflammation and apoptotic neurodegeneration in postnatal rat brain. Neurochemistry International 96, 1-12 (2016).
78. Shah, S. A. et al. Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits. Mole Psychiatry 1-10 (2016).
79. Lu, J. et al. Ursolic acid attenuates DGalactose-induced inflammatory response in mouse prefrontal cortex through inhibiting AGEs/RAGE/NF-kB pathway activation. Cereb Cortex 20, 2540-2548 (2010).